Skip to content

Benjamin Tsang

5 papers in the library · 14 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

Patient perspectives on research gaps in cluster headache.

Headache February 1, 2026 Faraidoon Haghdoost, Dilara Bahceci, Candice Delcourt et al.

This study was undertaken to identify gaps in cluster headache management, highlight patient-prioritized research needs, and assess patient interest in, and preferences for, clinical trial participation. Many people with cluster headache still lack effective treatment options to control or prevent attacks. There is a critical need for more studies, particularly clinical trials, in this field....

Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis

Neuroscience & Biobehavioral Reviews January 24, 2026 Omer A. Syed, Benjamin Tsang, Sean M. Nestor et al.

Psilocybin-assisted therapy (PAT) is an emerging intervention for depression. Though several clinical trials report promising results for PAT in treating depression, there remains a need for consensus on optimal methodologies and standardization of PAT protocols. The objective of this review was to assess the efficacy of PAT in treating depressive symptoms and to systematically examine the...

The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field

Neuroscience & Biobehavioral Reviews May 9, 2025 Rotem Petranker, Benjamin Tsang, Omer A. Syed 3 citations

Microdosing, the repeated use of psychedelic substances at low doses, is growing in popularity among recreational consumers. While this practice is associated with many benefits to mood, well-being and health, research in this area is in its early stages and predominantly centered on human applications. In this narrative review, we synthesize the findings from studies investigating the effects...

Managing expectations with psychedelic microdosing

npj Mental Health Research November 8, 2023 Omer A. Syed, Benjamin Tsang 4 citations

The recent years have seen an unprecedented surge of psychedelic research. Studies with psilocybin (colloquially known as magic mushrooms), in particular, have shown promise in ameliorating symptoms of treatment-refractory depression, anxiety, and substance use disorder, among others 1 , 2 . Microdosing, the practice of regularly taking roughly a tenth of full psychedelic doses, is becoming...

The zebrafish for preclinical psilocybin research.

Neuroscience and Biobehavioral Reviews October 1, 2023 Omer A. Syed, Benjamin Tsang, Robert Gerlai 7 citations

In this review, we discuss the possible utility of zebrafish in research on psilocybin, a psychedelic drug whose recreational use as well as possible clinical application are gaining increasing interest. First, we review behavioral tests with zebrafish, focussing on anxiety and social behavior, which have particular relevance in the context of psilocybin research. Next, we briefly consider...